Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Wells Fargo & Company
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $5.5M | 5.8M | 0.94 |
2023-12-31 | $7.5M | 7.6M | 0.99 |
2023-09-30 | $7.0M | 7.6M | 0.93 |
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1